$BNZI
Banzai International, Inc.

2024 Q3 Form 10-Q Financial Statement

#000095017024127232 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3
Revenue $1.081M $0.00
YoY Change
Cost Of Revenue $338.0K $341.2K
YoY Change -0.92%
Gross Profit $742.6K $767.3K
YoY Change -3.22%
Gross Profit Margin 68.72%
Selling, General & Admin $3.513M $809.7K
YoY Change 333.9% -31.06%
% of Gross Profit 473.14% 105.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $900.00 $1.571K
YoY Change -42.71%
% of Gross Profit 0.12% 0.2%
Operating Expenses $3.514M $809.7K
YoY Change 334.01% -31.06%
Operating Profit -$2.772M -$809.7K
YoY Change 242.31% -31.06%
Interest Expense -$1.138M $365.8K
YoY Change -411.15% -84.68%
% of Operating Profit
Other Income/Expense, Net -$12.64M $1.539K
YoY Change -821487.85%
Pretax Income -$15.41M -$442.4K
YoY Change 3383.96% -136.45%
Income Tax $1.010K $10.42K
% Of Pretax Income
Net Earnings -$15.41M -$452.8K
YoY Change 3303.99% -145.24%
Net Earnings / Revenue -1426.41%
Basic Earnings Per Share -$4.87 -$0.33
Diluted Earnings Per Share -$4.87 -$0.05
COMMON SHARES
Basic Shares Outstanding 3.163M 2.394M
Diluted Shares Outstanding 3.163M 2.394M

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.264M $399.5K
YoY Change 967.2% 23.71%
Cash & Equivalents $4.264M $399.5K
Short-Term Investments
Other Short-Term Assets $10.72K $85.54K
YoY Change -87.47% -3.15%
Inventory
Prepaid Expenses $85.54K
Receivables $37.39K $94.40K
Other Receivables $270.5K
Total Short-Term Assets $5.055M $485.1K
YoY Change 942.1% 17.95%
LONG-TERM ASSETS
Property, Plant & Equipment $918.00
YoY Change
Goodwill $2.172M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $82.38K $35.56M
YoY Change -99.77% -84.61%
Total Long-Term Assets $2.257M $35.56M
YoY Change -93.65% -84.61%
TOTAL ASSETS
Total Short-Term Assets $5.055M $485.1K
Total Long-Term Assets $2.257M $35.56M
Total Assets $7.312M $36.04M
YoY Change -79.71% -84.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.02M $2.486M
YoY Change 302.87% 63.51%
Accrued Expenses $3.121M $2.706M
YoY Change 15.32% 279.15%
Deferred Revenue
YoY Change
Short-Term Debt $1.418M $2.300M
YoY Change -38.35%
Long-Term Debt Due $9.255M
YoY Change
Total Short-Term Liabilities $30.08M $8.111M
YoY Change 270.87% 207.15%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $75.00K $9.747M
YoY Change -99.23% 15.66%
Total Long-Term Liabilities $75.00K $9.747M
YoY Change -99.23% 15.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $30.08M $8.111M
Total Long-Term Liabilities $75.00K $9.747M
Total Liabilities $30.16M $17.86M
YoY Change 68.88% 61.35%
SHAREHOLDERS EQUITY
Retained Earnings -$70.40M -$17.29M
YoY Change 307.16% 67.76%
Common Stock $410.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$22.85M -$17.29M
YoY Change
Total Liabilities & Shareholders Equity $7.312M $36.04M
YoY Change -79.71% -84.43%

Cashflow Statement

Concept 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$15.41M -$452.8K
YoY Change 3303.99% -145.24%
Depreciation, Depletion And Amortization $900.00 $1.571K
YoY Change -42.71%
Cash From Operating Activities -$1.550M -$188.5K
YoY Change 722.27% -39.99%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $18.44M
YoY Change 4500.06%
Cash From Investing Activities $18.44M
YoY Change 4500.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.342M -18.44M
YoY Change -128.96%
NET CHANGE
Cash From Operating Activities -1.550M -188.5K
Cash From Investing Activities 18.44M
Cash From Financing Activities 5.342M -18.44M
Net Change In Cash 3.792M -187.3K
YoY Change -2124.04% -315.9%
FREE CASH FLOW
Cash From Operating Activities -$1.550M -$188.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001826011
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.02
CY2024Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.02
us-gaap Restructuring And Related Activities Completion Date
RestructuringAndRelatedActivitiesCompletionDate
2024-10-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39826
dei Entity Registrant Name
EntityRegistrantName
Banzai International, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3118980
dei Entity Address Address Line1
EntityAddressAddressLine1
435 Ericksen Ave
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 250
dei Entity Address City Or Town
EntityAddressCityOrTown
Bainbridge Island
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98110
dei City Area Code
CityAreaCode
206
dei Local Phone Number
LocalPhoneNumber
414-1777
dei Security12b Title
Security12bTitle
Class A common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
BNZI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4263567
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2093718
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5694
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5748
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
37386
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
105049
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
753746
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
741155
CY2024Q3 us-gaap Assets Current
AssetsCurrent
5054699
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2939922
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
918
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4644
CY2024Q3 us-gaap Goodwill
Goodwill
2171526
CY2023Q4 us-gaap Goodwill
Goodwill
2171526
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2386
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
134013
CY2024Q3 us-gaap Other Assets
OtherAssets
38381
CY2023Q4 us-gaap Other Assets
OtherAssets
38381
CY2024Q3 us-gaap Assets
Assets
7311910
CY2023Q4 us-gaap Assets
Assets
5288486
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10016295
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6439863
CY2024Q3 bnzi Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3803915
CY2023Q4 bnzi Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
5194240
CY2024Q3 bnzi Notes Payable Carried At Fair Value Current
NotesPayableCarriedAtFairValueCurrent
1418000
CY2023Q4 bnzi Notes Payable Carried At Fair Value Current
NotesPayableCarriedAtFairValueCurrent
0
CY2024Q3 bnzi Deferred Underwriting Fees Current
DeferredUnderwritingFeesCurrent
4000000
CY2023Q4 bnzi Deferred Underwriting Fees Current
DeferredUnderwritingFeesCurrent
4000000
CY2024Q3 bnzi Deferred Fee Current
DeferredFeeCurrent
0
CY2023Q4 bnzi Deferred Fee Current
DeferredFeeCurrent
500000
CY2024Q3 bnzi Earnout Liability Current
EarnoutLiabilityCurrent
37125
CY2023Q4 bnzi Earnout Liability Current
EarnoutLiabilityCurrent
59399
CY2024Q3 bnzi Due To Related Parties
DueToRelatedParties
167118
CY2023Q4 bnzi Due To Related Parties
DueToRelatedParties
67118
CY2024Q3 bnzi Gem Commitment Fee Liability
GemCommitmentFeeLiability
0
CY2023Q4 bnzi Gem Commitment Fee Liability
GemCommitmentFeeLiability
2000000
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1220572
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1214096
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2352
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
234043
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
30082607
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
37089615
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
75000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
75000
CY2024Q3 us-gaap Liabilities
Liabilities
30157607
CY2023Q4 us-gaap Liabilities
Liabilities
37164615
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4303443
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4303443
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2585297
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2585297
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
410
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
259
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
47579604
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14889936
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-70425711
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46766324
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-22845697
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-31876129
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7311910
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5288486
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1080607
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1108412
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3228276
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3478794
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
338023
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
341151
us-gaap Cost Of Revenue
CostOfRevenue
1049411
us-gaap Cost Of Revenue
CostOfRevenue
1132671
CY2024Q3 us-gaap Gross Profit
GrossProfit
742584
CY2023Q3 us-gaap Gross Profit
GrossProfit
767261
us-gaap Gross Profit
GrossProfit
2178865
us-gaap Gross Profit
GrossProfit
2346123
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3513442
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2838052
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11721465
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8937265
CY2024Q3 us-gaap Depreciation
Depreciation
900
CY2023Q3 us-gaap Depreciation
Depreciation
1571
us-gaap Depreciation
Depreciation
3725
us-gaap Depreciation
Depreciation
5596
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
3514342
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
2839623
us-gaap Operating Expenses
OperatingExpenses
11725190
us-gaap Operating Expenses
OperatingExpenses
8942861
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2771758
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2072362
us-gaap Operating Income Loss
OperatingIncomeLoss
-9546325
us-gaap Operating Income Loss
OperatingIncomeLoss
-6596738
CY2024Q3 bnzi Gem Settlement Fee Expense
GemSettlementFeeExpense
60000
CY2023Q3 bnzi Gem Settlement Fee Expense
GemSettlementFeeExpense
0
bnzi Gem Settlement Fee Expense
GemSettlementFeeExpense
260000
bnzi Gem Settlement Fee Expense
GemSettlementFeeExpense
0
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
62927
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14114
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2900
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
70569
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
us-gaap Investment Income Interest
InvestmentIncomeInterest
10
us-gaap Investment Income Interest
InvestmentIncomeInterest
111
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
152782
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
680762
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2024Q3 bnzi Gains Losses On Debt Issuance
GainsLossesOnDebtIssuance
0
CY2023Q3 bnzi Gains Losses On Debt Issuance
GainsLossesOnDebtIssuance
0
bnzi Gains Losses On Debt Issuance
GainsLossesOnDebtIssuance
171000
bnzi Gains Losses On Debt Issuance
GainsLossesOnDebtIssuance
0
CY2024Q3 bnzi Gain Loss On Issuance Of Term Notes
GainLossOnIssuanceOfTermNotes
-390000
CY2023Q3 bnzi Gain Loss On Issuance Of Term Notes
GainLossOnIssuanceOfTermNotes
0
bnzi Gain Loss On Issuance Of Term Notes
GainLossOnIssuanceOfTermNotes
-390000
bnzi Gain Loss On Issuance Of Term Notes
GainLossOnIssuanceOfTermNotes
0
CY2024Q3 bnzi Gain Loss On Issuance Of Convertible Bridge Notes
GainLossOnIssuanceOfConvertibleBridgeNotes
-63408
CY2023Q3 bnzi Gain Loss On Issuance Of Convertible Bridge Notes
GainLossOnIssuanceOfConvertibleBridgeNotes
0
bnzi Gain Loss On Issuance Of Convertible Bridge Notes
GainLossOnIssuanceOfConvertibleBridgeNotes
-63408
bnzi Gain Loss On Issuance Of Convertible Bridge Notes
GainLossOnIssuanceOfConvertibleBridgeNotes
0
CY2024Q3 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-101000
CY2023Q3 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
0
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-679000
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
0
CY2024Q3 bnzi Change In Fair Value Of Term Notes
ChangeInFairValueOfTermNotes
36813
CY2023Q3 bnzi Change In Fair Value Of Term Notes
ChangeInFairValueOfTermNotes
0
bnzi Change In Fair Value Of Term Notes
ChangeInFairValueOfTermNotes
36813
bnzi Change In Fair Value Of Term Notes
ChangeInFairValueOfTermNotes
0
CY2024Q3 bnzi Change In Fair Value Of Convertible Bridge Notes
ChangeInFairValueOfConvertibleBridgeNotes
-18000
CY2023Q3 bnzi Change In Fair Value Of Convertible Bridge Notes
ChangeInFairValueOfConvertibleBridgeNotes
0
bnzi Change In Fair Value Of Convertible Bridge Notes
ChangeInFairValueOfConvertibleBridgeNotes
-18000
bnzi Change In Fair Value Of Convertible Bridge Notes
ChangeInFairValueOfConvertibleBridgeNotes
0
CY2024Q3 bnzi Yorkville Prepayment Premium Expense
YorkvillePrepaymentPremiumExpense
-14000
CY2023Q3 bnzi Yorkville Prepayment Premium Expense
YorkvillePrepaymentPremiumExpense
0
bnzi Yorkville Prepayment Premium Expense
YorkvillePrepaymentPremiumExpense
-94760
bnzi Yorkville Prepayment Premium Expense
YorkvillePrepaymentPremiumExpense
0
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12641159
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1291392
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14106361
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1419658
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15412917
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-780970
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23652686
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8016396
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1010
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1332
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6701
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17081
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-15413927
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-782302
us-gaap Net Income Loss
NetIncomeLoss
-23659387
us-gaap Net Income Loss
NetIncomeLoss
-8033477
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.87
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.87
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.36
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3162909
CY2024Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3162909
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2394122
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2394122
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2861665
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2861665
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2394067
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2394067
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-31876129
CY2024Q1 bnzi Share Issued To Roth For Advisory Fee
ShareIssuedToRothForAdvisoryFee
278833
CY2024Q1 bnzi Stock Issued During Period Sharesissued Formarketing Expenses
StockIssuedDuringPeriodSharesissuedFormarketingExpenses
194935
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
42827
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-4290132
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-30842575
CY2024Q2 bnzi Issuance Of Common Stock And Warrants Net Of Issuance Costs
IssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts
1854818
CY2024Q2 bnzi Stock Issued During Period Value Exercise Of Pre Funded Warrants
StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants
866
CY2024Q2 bnzi Stock Issued During Period Sharesissued Formarketing Expenses
StockIssuedDuringPeriodSharesissuedFormarketingExpenses
139837
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
202662
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-3955328
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-31848920
CY2024Q3 bnzi Issuance Of Warrants Net Of Issuance Costs
IssuanceOfWarrantsNetOfIssuanceCosts
4402550
CY2024Q3 bnzi Shares Warrants And Pre Funded Warrants Issued To Cp Bf On Modification Of Cp Bf Debt Agreement
SharesWarrantsAndPreFundedWarrantsIssuedToCpBfOnModificationOfCpBfDebtAgreement
1287003
CY2024Q3 bnzi Premium Issued As Part Of Cp Bf Debt Modification
PremiumIssuedAsPartOfCpBfDebtModification
4079225
CY2024Q3 bnzi Issuance Of Warrants To Cp Bf Net Of Issuance Costs
IssuanceOfWarrantsToCpBfNetOfIssuanceCosts
2763161
CY2024Q3 bnzi Shares Issued To Mzhci For Investor Relations Services
SharesIssuedToMzhciForInvestorRelationsServices
94800
CY2024Q3 bnzi Share Issued To Roth For Advisory Fee
ShareIssuedToRothForAdvisoryFee
300000
CY2024Q3 bnzi Shares Issued To Jvb For Payment Of Outstanding Debt
SharesIssuedToJVBForPaymentOfOutstandingDebt
115000
CY2024Q3 bnzi Shares Warrants And Pre Funded Warrants Issued To Alco On Settlement Of Alco Promissory Notes
SharesWarrantsAndPreFundedWarrantsIssuedToAlcoOnSettlementOfAlcoPromissoryNotes
8866620
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
250848
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-15413927
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-22845697
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-24114058
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5543
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
402448
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3765122
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-27471189
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7820
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
218539
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3486053
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-30730883
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
209804
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-782302
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-31303381
us-gaap Net Income Loss
NetIncomeLoss
-23659387
us-gaap Net Income Loss
NetIncomeLoss
-8033477
us-gaap Depreciation
Depreciation
3725
us-gaap Depreciation
Depreciation
5596
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
54
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3879
bnzi Non Cash Share Issuance For Marketing Expenses
NonCashShareIssuanceForMarketingExpenses
259027
bnzi Non Cash Share Issuance For Marketing Expenses
NonCashShareIssuanceForMarketingExpenses
0
bnzi Non Cash Settlement Of Gem Commitment Fee
NonCashSettlementOfGemCommitmentFee
-200000
bnzi Non Cash Settlement Of Gem Commitment Fee
NonCashSettlementOfGemCommitmentFee
0
bnzi Non Cash Share Issuance For Yorkville Redemption Premium
NonCashShareIssuanceForYorkvilleRedemptionPremium
80760
bnzi Non Cash Share Issuance For Yorkville Redemption Premium
NonCashShareIssuanceForYorkvilleRedemptionPremium
0
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
131627
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
129705
us-gaap Share Based Compensation
ShareBasedCompensation
496337
us-gaap Share Based Compensation
ShareBasedCompensation
830791
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
680762
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
bnzi Gains Losses On Debt Issuance
GainsLossesOnDebtIssuance
171000
bnzi Gains Losses On Debt Issuance
GainsLossesOnDebtIssuance
0
bnzi Gain Loss On Issuance Of Term Notes
GainLossOnIssuanceOfTermNotes
-390000
bnzi Gain Loss On Issuance Of Term Notes
GainLossOnIssuanceOfTermNotes
0
bnzi Gain Loss On Issuance Of Convertible Bridge Notes
GainLossOnIssuanceOfConvertibleBridgeNotes
-63408
bnzi Gain Loss On Issuance Of Convertible Bridge Notes
GainLossOnIssuanceOfConvertibleBridgeNotes
0
bnzi Change In Fair Value Of Convertible Promissory Notes
ChangeInFairValueOfConvertiblePromissoryNotes
693000
bnzi Change In Fair Value Of Convertible Promissory Notes
ChangeInFairValueOfConvertiblePromissoryNotes
0
bnzi Change In Fair Value Of Term Notes
ChangeInFairValueOfTermNotes
36813
bnzi Change In Fair Value Of Term Notes
ChangeInFairValueOfTermNotes
0
bnzi Change In Fair Value Of Convertible Bridge Notes
ChangeInFairValueOfConvertibleBridgeNotes
-18000
bnzi Change In Fair Value Of Convertible Bridge Notes
ChangeInFairValueOfConvertibleBridgeNotes
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-67609
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
29861
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-48191
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-157954
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-120459
bnzi Deferred Offering Costs Operating Activities
DeferredOfferingCostsOperatingActivities
0
bnzi Deferred Offering Costs Operating Activities
DeferredOfferingCostsOperatingActivities
766409
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3576434
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1296098
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6476
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-39428
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-15730
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-128027
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-231691
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-211204
bnzi Increase Decrease In Earnout Liability
IncreaseDecreaseInEarnoutLiability
-22274
bnzi Increase Decrease In Earnout Liability
IncreaseDecreaseInEarnoutLiability
-206985
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5363004
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5808100
bnzi Payment Of Gem Commitment Fee
PaymentOfGemCommitmentFee
1200000
bnzi Payment Of Gem Commitment Fee
PaymentOfGemCommitmentFee
0
bnzi Proceeds From Related Party Advance
ProceedsFromRelatedPartyAdvance
100000
bnzi Proceeds From Related Party Advance
ProceedsFromRelatedPartyAdvance
0
us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
1000000
us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
0
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
412421
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0
bnzi Proceeds From Yorkville Redemption Premium
ProceedsFromYorkvilleRedemptionPremium
35040
bnzi Proceeds From Yorkville Redemption Premium
ProceedsFromYorkvilleRedemptionPremium
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1150000
bnzi Proceeds Received For Exercise Of Pre Funded Warrants
ProceedsReceivedForExerciseOfPreFundedWarrants
866
bnzi Proceeds Received For Exercise Of Pre Funded Warrants
ProceedsReceivedForExerciseOfPreFundedWarrants
0
bnzi Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
6257368
bnzi Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
13362
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7532853
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5181362
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2169849
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-626738
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2093718
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1023499
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4263567
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
396761
us-gaap Interest Paid Net
InterestPaidNet
306109
us-gaap Interest Paid Net
InterestPaidNet
313813
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5075
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8825
bnzi Shares Issued To Roth For Advisory Fee Amount
SharesIssuedToRothForAdvisoryFeeAmount
578833
bnzi Shares Issued To Roth For Advisory Fee Amount
SharesIssuedToRothForAdvisoryFeeAmount
0
us-gaap Stock Issued1
StockIssued1
529943
us-gaap Stock Issued1
StockIssued1
0
bnzi Shares Issued For Marketing Expenses
SharesIssuedForMarketingExpenses
334772
bnzi Shares Issued For Marketing Expenses
SharesIssuedForMarketingExpenses
0
bnzi Shares Issued For Investor Relations Services
SharesIssuedForInvestorRelationsServices
94800
bnzi Shares Issued For Investor Relations Services
SharesIssuedForInvestorRelationsServices
0
bnzi Shares Issued For Payment Of Outstanding Debt
SharesIssuedForPaymentOfOutstandingDebt
115000
bnzi Shares Issued For Payment Of Outstanding Debt
SharesIssuedForPaymentOfOutstandingDebt
0
bnzi Settlement Of Gem Commitment Fee
SettlementOfGemCommitmentFee
200000
bnzi Settlement Of Gem Commitment Fee
SettlementOfGemCommitmentFee
0
bnzi Shares Issued To Yorkville For Aggregate Commitment Fee
SharesIssuedToYorkvilleForAggregateCommitmentFee
500000
bnzi Shares Issued To Yorkville For Aggregate Commitment Fee
SharesIssuedToYorkvilleForAggregateCommitmentFee
0
bnzi Shares Issued To Yorkville For Redemption Premium
SharesIssuedToYorkvilleForRedemptionPremium
115800
bnzi Shares Issued To Yorkville For Redemption Premium
SharesIssuedToYorkvilleForRedemptionPremium
0
bnzi Shares Issued For Exercise Of Pre Funded Warrants
SharesIssuedForExerciseOfPreFundedWarrants
866
bnzi Shares Issued For Exercise Of Pre Funded Warrants
SharesIssuedForExerciseOfPreFundedWarrants
0
bnzi Issuance Of Convertible Promissory Note
IssuanceOfConvertiblePromissoryNote
1000000
bnzi Issuance Of Convertible Promissory Note
IssuanceOfConvertiblePromissoryNote
0
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2015-09-30
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On August 29, 2024, the Company held a special meeting of securityholders (the “Special Meeting”). At the Special Meeting, the Company’s securityholders approved the proposal to amend the Second Amended and Restated Certificate of Incorporation to effect a reverse stock split with respect to the Company’s issued and outstanding Class A Common Stock, at a ratio of up to 1-for-50, with the final ratio and exact timing to be determined at the discretion of the Board of Directors (the "Reverse Stock Split"). On September 10, 2024, the Board determined to effect a reverse stock split at a ratio of 1-for-50, effective as of September 19, 2024 and filed an amendment with the Secretary of State of the State of Delaware. The Class B Common Stock was not affected by the Reverse Stock Split.
us-gaap Error Corrections And Prior Period Adjustments Description
ErrorCorrectionsAndPriorPeriodAdjustmentsDescription
A revision was made to correct an overstatement of additional paid-in capital and accumulated deficit in the Company's consolidated balance sheet and an overstatement of stock-based compensation expense in the statement of operations due to the incorrect calculation of stock-based compensation expense for the three-month periods ended March 31, 2024 and June 30, 2024. The adjustment recorded increased equity and decreased stock-based compensation expense by $210,140 for the three months ended March 31, 2024. During the three months ended June 30, 2024, the adjustment recorded increased equity and decreased stock-based compensation expense by $209,780, resulting in a cumulative adjustment of $419,921 to the six months ended June 30, 2024.
CY2024Q3 us-gaap Cash
Cash
4300000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5400000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-70400000
CY2024Q3 us-gaap Restructuring And Related Activities Initiation Date
RestructuringAndRelatedActivitiesInitiationDate
2024-09-16
CY2024Q3 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
24
CY2024Q3 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.34
CY2024Q3 us-gaap Effect On Future Earnings And Cash Flows Income Statement Line Item Impacted
EffectOnFutureEarningsAndCashFlowsIncomeStatementLineItemImpacted
operating expenses
CY2024Q3 bnzi Expected Decrease In Annual Operating Expenses Due To Reduction
ExpectedDecreaseInAnnualOperatingExpensesDueToReduction
1300000
CY2024Q3 us-gaap Restructuring Charges
RestructuringCharges
100000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15413927
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-15413927
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-782302
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-782302
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23659387
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-23659387
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8033477
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8033477
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3162909
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3162909
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2394122
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2394122
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2861665
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2861665
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2394067
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2394067
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.87
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.87
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.36
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7452628
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13649
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
1
CY2024Q3 us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
2
CY2024Q3 us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
1
CY2024Q3 us-gaap Debt Instrument Issuance Date1
DebtInstrumentIssuanceDate1
2024-09-23
bnzi Payment Term
PaymentTerm
P30D
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1080607
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1108412
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3228276
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3478794
bnzi Accounts Receivable Contractual Term
AccountsReceivableContractualTerm
The Company receives payments from customers based upon agreed-upon contractual terms, typically within 30 days of invoicing the customer.
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
105049
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
37386
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
68416
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
94398
CY2024Q3 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
50707
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
193995
CY2023Q3 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
91929
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
282548
CY2024Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
37118
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
51472
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
51472
CY2024Q1 bnzi Commissions Incurred
CommissionsIncurred
31610
CY2024Q1 bnzi Deferred Commissions Recognized
DeferredCommissionsRecognized
44620
CY2024Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
38462
CY2024Q2 bnzi Commissions Incurred
CommissionsIncurred
48316
CY2024Q2 bnzi Deferred Commissions Recognized
DeferredCommissionsRecognized
47634
CY2024Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
39144
CY2024Q3 bnzi Commissions Incurred
CommissionsIncurred
42739
CY2024Q3 bnzi Deferred Commissions Recognized
DeferredCommissionsRecognized
44765
CY2024Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
37118
CY2022Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
69737
CY2023Q1 bnzi Commissions Incurred
CommissionsIncurred
88928
CY2023Q1 bnzi Deferred Commissions Recognized
DeferredCommissionsRecognized
104289
CY2023Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
54376
CY2023Q2 bnzi Commissions Incurred
CommissionsIncurred
60777
CY2023Q2 bnzi Deferred Commissions Recognized
DeferredCommissionsRecognized
75001
CY2023Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
40152
CY2023Q3 bnzi Commissions Incurred
CommissionsIncurred
50845
CY2023Q3 bnzi Deferred Commissions Recognized
DeferredCommissionsRecognized
69451
CY2023Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
21546
CY2024Q3 bnzi Bifurcated Embedded Derivative Liabilities Current
BifurcatedEmbeddedDerivativeLiabilitiesCurrent
0
CY2023Q4 bnzi Bifurcated Embedded Derivative Liabilities Current
BifurcatedEmbeddedDerivativeLiabilitiesCurrent
0
CY2024Q3 bnzi Bifurcated Embedded Derivative Assets Current
BifurcatedEmbeddedDerivativeAssetsCurrent
44000
CY2024Q3 bnzi Conversion Upon Simple Agreements For Future Equity
ConversionUponSimpleAgreementsForFutureEquity
0
CY2023Q4 bnzi Conversion Upon Simple Agreements For Future Equity
ConversionUponSimpleAgreementsForFutureEquity
0
CY2024Q3 bnzi Service Trade
ServiceTrade
270548
CY2023Q4 bnzi Service Trade
ServiceTrade
364384
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
135457
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
17661
CY2024Q3 bnzi Prepaid Consulting Costs
PrepaidConsultingCosts
116407
CY2023Q4 bnzi Prepaid Consulting Costs
PrepaidConsultingCosts
120332
CY2024Q3 bnzi Prepaid Software Costs
PrepaidSoftwareCosts
74158
CY2023Q4 bnzi Prepaid Software Costs
PrepaidSoftwareCosts
29887
CY2024Q3 us-gaap Prepaid Advertising
PrepaidAdvertising
64092
CY2023Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
11074
CY2024Q3 bnzi Prepaid Commissions
PrepaidCommissions
37118
CY2023Q4 bnzi Prepaid Commissions
PrepaidCommissions
51472
CY2024Q3 bnzi Prepaid Merchant Fees
PrepaidMerchantFees
26497
CY2023Q4 bnzi Prepaid Merchant Fees
PrepaidMerchantFees
26224
CY2024Q3 bnzi Prepaid Data License And Subscription Costs
PrepaidDataLicenseAndSubscriptionCosts
18750
CY2023Q4 bnzi Prepaid Data License And Subscription Costs
PrepaidDataLicenseAndSubscriptionCosts
53124
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
10719
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
66997
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
753746
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
741155
CY2024Q3 bnzi Accrued Accounting And Professional Services Costs
AccruedAccountingAndProfessionalServicesCosts
2776213
CY2023Q4 bnzi Accrued Accounting And Professional Services Costs
AccruedAccountingAndProfessionalServicesCosts
1511889
CY2024Q3 bnzi Sales Tax Payable Current
SalesTaxPayableCurrent
388777
CY2023Q4 bnzi Sales Tax Payable Current
SalesTaxPayableCurrent
314873
CY2024Q3 bnzi Excise Tax Payable Current
ExciseTaxPayableCurrent
223717
CY2023Q4 bnzi Excise Tax Payable Current
ExciseTaxPayableCurrent
223717
CY2024Q3 bnzi Accrued Legal Costs
AccruedLegalCosts
153977
CY2023Q4 bnzi Accrued Legal Costs
AccruedLegalCosts
2694439
CY2024Q3 bnzi Accrued Payroll And Benefit Costs
AccruedPayrollAndBenefitCosts
111264
CY2023Q4 bnzi Accrued Payroll And Benefit Costs
AccruedPayrollAndBenefitCosts
185504
CY2024Q3 bnzi Accrued Streaming Service Costs
AccruedStreamingServiceCosts
47147
CY2023Q4 bnzi Accrued Streaming Service Costs
AccruedStreamingServiceCosts
37765
CY2024Q3 bnzi Accrued Subscription Costs
AccruedSubscriptionCosts
29552
CY2023Q4 bnzi Accrued Subscription Costs
AccruedSubscriptionCosts
22110
CY2024Q3 us-gaap Deposit Liability Current
DepositLiabilityCurrent
0
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
54102
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
73268
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
149841
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
3803915
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
5194240
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
874119
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
919764
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1214096
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
930436
bnzi Contract With Customer Liability Billings
ContractWithCustomerLiabilityBillings
3234752
CY2023 bnzi Contract With Customer Liability Billings
ContractWithCustomerLiabilityBillings
4781924
bnzi Contract With Customer Liability Revenue Recognition Of Deferred Revenue Prior Year
ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenuePriorYear
-874119
CY2023 bnzi Contract With Customer Liability Revenue Recognition Of Deferred Revenue Prior Year
ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenuePriorYear
-930436
bnzi Contract With Customer Liability Revenue Recognition Of Deferred Revenue Current Year
ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenueCurrentYear
-2354157
CY2023 bnzi Contract With Customer Liability Revenue Recognition Of Deferred Revenue Current Year
ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenueCurrentYear
-3567828
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1220572
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1214096
CY2023Q4 bnzi Number Of Promissory Notes In Connection With Merger
NumberOfPromissoryNotesInConnectionWithMerger
2
bnzi Warrants Exercise Price Description
WarrantsExercisePriceDescription
The Public Warrants have an exercise price of $575.00 per share, subject to adjustments, and will expire five years from the Merger Closing Date. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation.
bnzi Contractual Term
ContractualTerm
P60D
bnzi Warrants Exercisable Description
WarrantsExercisableDescription
Once the Public Warrants become exercisable, the Company may redeem the outstanding Public Warrants:•in whole and not in part;•at a price of $25.00 per Warrant;•upon a minimum of 30 days' prior written notice of redemption (the "30-day redemption period"); and•if, and only if, the closing price per share of Class A Common Stock equals or exceeds $900.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a Public Warrant as described under the heading “- Warrants—Public Stockholder Warrants—Anti-dilution Adjustments”) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders.
CY2024Q3 bnzi Fair Value Of Warrants
FairValueOfWarrants
47000
CY2023Q4 bnzi Fair Value Of Warrants
FairValueOfWarrants
641000
CY2024Q3 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P0Y29D
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
44999
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
49394
CY2024Q3 us-gaap Sublease Income
SubleaseIncome
12000
CY2023Q3 us-gaap Sublease Income
SubleaseIncome
51083
CY2024Q3 us-gaap Lease Cost
LeaseCost
32999
CY2023Q3 us-gaap Lease Cost
LeaseCost
-1689
us-gaap Operating Lease Cost
OperatingLeaseCost
138383
us-gaap Operating Lease Cost
OperatingLeaseCost
151282
us-gaap Sublease Income
SubleaseIncome
117084
us-gaap Sublease Income
SubleaseIncome
153248
us-gaap Lease Cost
LeaseCost
21299
us-gaap Lease Cost
LeaseCost
-1966
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
131627
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
129705
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-231691
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-211204
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2386
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
134013
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2352
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
234043
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2352
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
234043
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y29D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y9M3D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1016
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0676
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2372
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2372
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
20
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2352
bnzi Addendum To Letter Agreements Description
AddendumToLetterAgreementsDescription
where the Company agreed to pay the fees owed under the Roth Agreement and 7GC Agreement by (1) issuing to Roth 175,000 Shares and amending the Company’s registration statement on Form S-1 filed with the SEC on December 29, 2023 to include the initial 175,000 Shares to be issued, and 600,000 Shares that may be issued as additional shares, as defined in the Addendum, to Roth, and (2) on or before June 30, 2024, the Company shall pay to Roth an amount in cash equal to $300,000 (the “Cash Fee”); provided that, if, as a result of the Company’s cash position at such time, the Company determines in its reasonable discretion that the cash payment should not be made in cash, then the Company may elect to satisfy the cash payment by issuing to Roth, within three business days of such date, additional Shares.
CY2024Q3 bnzi Aggregate Share Cancellation Value
AggregateShareCancellationValue
4472738
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Common Stock Voting Rights
CommonStockVotingRights
The Class A Common Stock and Class B Common Stock entitle their holders to one vote per share and ten votes per share, respectively, on each matter properly submitted to the stockholders entitled to vote thereon.
CY2024Q2 us-gaap Legal Fees
LegalFees
409000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 us-gaap Share Price
SharePrice
352
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
368
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.61
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.6212
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.80
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.9903
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.042
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0445
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0346
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0431
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16445
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
313.22
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y5M4D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
27970
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
145.7
bnzi Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y7M13D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
826
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
363.53
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
16643
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
261.12
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
26946
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
169.19
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M29D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7238
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
187.6
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y2M8D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
187.44
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
248
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
591887
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2190563
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y6M18D
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M15D
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-127232-index-headers.html Edgar Link pending
0000950170-24-127232-index.html Edgar Link pending
0000950170-24-127232.txt Edgar Link pending
0000950170-24-127232-xbrl.zip Edgar Link pending
bnzi-20240930.htm Edgar Link pending
bnzi-20240930.xsd Edgar Link pending
bnzi-ex10_30.htm Edgar Link pending
bnzi-ex10_31.htm Edgar Link pending
bnzi-ex10_32.htm Edgar Link pending
bnzi-ex31_1.htm Edgar Link pending
bnzi-ex31_2.htm Edgar Link pending
bnzi-ex32_1.htm Edgar Link pending
bnzi-ex32_2.htm Edgar Link pending
bnzi-ex4_8.htm Edgar Link pending
bnzi-ex4_9.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
bnzi-20240930_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable